Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients-Reference-Cited by-同舟云学术

Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients

Published:2015-08-22 Issue:11 Volume:94 Page:1829-1837
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Lou Yinjun,Ma Yafang,Sun Jianai,Ye Xiujin,Pan Hanzhang,Wang Yungui,Qian Wenbin,Meng Haitao,Mai Wenyuan,He JingSong,Tong Hongyan,Jin Jie

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-015-2477-x.pdf

Reference29 articles.

1. Kakizuka A, Miller WH Jr, Umesono K et al (1991) Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66(4):663–674

2. de The H, Lavau C, Marchio A et al (1991) The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66(4):675–684

3. Zhang XW, Yan XJ, Zhou ZR et al (2010) Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. Science 328(5975):240–243. doi: 10.1126/science.1183424

4. Jeanne M, Lallemand-Breitenbach V, Ferhi O et al (2010) PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3. Cancer Cell 18(1):88–98. doi: 10.1016/j.ccr.2010.06.003

5. Tomita A, Kiyoi H, Naoe T (2013) Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O 3) in acute promyelocytic leukemia. Int J Hematol 97(6):717–725. doi: 10.1007/s12185-013-1354-4

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Realgar-indigo naturalis formula for the treatment of patients with relapsed and arsenic trioxide-resistant acute promyelocytic leukemia: A case series;Journal of Integrative Medicine;2024-08

2. Research on different compound combinations of Realgar-Indigo naturalis formula to reverse acute promyelocytic leukemia arsenic resistance by regulating autophagy through mTOR pathway;Journal of Ethnopharmacology;2024-05

3. Risk factors and remaining challenges in the treatment of acute promyelocytic leukemia;International Journal of Hematology;2024-02-22

4. Mutations at proximal cysteine residues in PML impair ATO binding by destabilizing the RBCC domain;The FEBS Journal;2023-12-28

5. Research on compound combination of Realgar-Indigo naturalis Formula to reverse APL arsenic resistance by regulating autophagy through mTOR pathway;2023-06-29